C. elegans to study organismal control of recovery from bacterial infections

线虫研究细菌感染恢复的有机控制

基本信息

  • 批准号:
    9027974
  • 负责人:
  • 金额:
    $ 39.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-11-05 至 2020-10-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant) This proposal describes experiments designed to understand the mechanisms involved in the control of recovery from bacterial infections. To recover from an infection and return to homeostasis, the host must activate mechanisms capable of controlling the damage caused by pathogen virulence factors, inflammation, and a potentially toxic antibiotic exposure. Failure to properly recover from infections manifests in the form of recurrent infections, inappropriate wound healing, autoimmune diseases, and chronic inflammatory disorders. The mechanisms involved in pathogen recognition and immune activation have been very well studied, but the cellular and systemic responses involved in recovery after an infection is cleared are not well defined. We have established a Caenorhabditis elegans model of acute infection and antibiotic treatment for studying biological changes during the resolution phase of an infection. We found that genes that are markers of innate immunity are downregulated upon recovery, while genes involved in xenobiotic detoxification, redox regulation, and cellular homeostasis are upregulated. Using gene expression profiling, in silico analysis, and reverse genetic approaches, we have linked to the control of recovery from infection to the function of conserved transcription factors, including th GATA transcription factor ELT-2, the FOXO transcription factor DAF-16, and the Nrf transcription factor SKN-1. The proposed experiments will explore the general hypothesis that neural GPCRs and cell non-autonomous signals from different neurons may act on non-neural tissues to regulate recovery from infection at the organismal level. Given the conserved nature of GPCR-mediated signaling and the conservation of the transcription factors involved in the control of recovery, the proposed studies should lead to a better understanding of the mechanisms used by metazoans to control recovery from bacterial infection at the whole animal level.
 描述(申请人证明)该提案旨在了解涉及细菌感染的含量的机制。在 反复发作的不适,伤口愈合,自身免疫性疾病和慢性炎症疾病{在研究生物学的抗生素治疗中,建立了一种感染的生物学!转录因子ELT-2,FOXO转录因子DAF-16和NRF转录因子SKN-1。神经组织从生物水平的感染中恢复。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alejandro Aballay其他文献

Alejandro Aballay的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alejandro Aballay', 18)}}的其他基金

Mechanism of innate immune activation by intestinal distension
肠扩张激活先天免疫的机制
  • 批准号:
    10268229
  • 财政年份:
    2020
  • 资助金额:
    $ 39.46万
  • 项目类别:
Mechanism of innate immune activation by intestinal distension
肠扩张激活先天免疫的机制
  • 批准号:
    10674045
  • 财政年份:
    2020
  • 资助金额:
    $ 39.46万
  • 项目类别:
Mechanism of innate immune activation by intestinal distension
肠扩张激活先天免疫的机制
  • 批准号:
    10458056
  • 财政年份:
    2020
  • 资助金额:
    $ 39.46万
  • 项目类别:
C. elegans to study organismal control of recovery from bacterial infections
线虫研究细菌感染恢复的有机控制
  • 批准号:
    9176010
  • 财政年份:
    2015
  • 资助金额:
    $ 39.46万
  • 项目类别:
Regulation of Innate Immunity by Virulence Factors
毒力因子对先天免疫的调节
  • 批准号:
    7090098
  • 财政年份:
    2005
  • 资助金额:
    $ 39.46万
  • 项目类别:
Regulation of Innate Immunity by Virulence Factors
毒力因子对先天免疫的调节
  • 批准号:
    6958609
  • 财政年份:
    2005
  • 资助金额:
    $ 39.46万
  • 项目类别:
Genetic analysis of innate immunity using C. elegans
使用秀丽隐杆线虫进行先天免疫的遗传分析
  • 批准号:
    9593433
  • 财政年份:
    2004
  • 资助金额:
    $ 39.46万
  • 项目类别:
Genetic analysis of innate immunity using C. elegans
使用秀丽隐杆线虫进行先天免疫的遗传分析
  • 批准号:
    9388780
  • 财政年份:
    2004
  • 资助金额:
    $ 39.46万
  • 项目类别:
Genetic analysis of innate immunity using C. elegans
使用秀丽隐杆线虫进行先天免疫的遗传分析
  • 批准号:
    9176598
  • 财政年份:
    2004
  • 资助金额:
    $ 39.46万
  • 项目类别:
Genetic analysis of innate immunity using C. elegans
使用秀丽隐杆线虫进行先天免疫的遗传分析
  • 批准号:
    7279917
  • 财政年份:
    2004
  • 资助金额:
    $ 39.46万
  • 项目类别:

相似国自然基金

SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
  • 批准号:
    82300764
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
  • 批准号:
    82370175
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
  • 批准号:
    82370165
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML
用于儿科 AML 可测量残留疾病监测的个性化分子检测的临床前验证
  • 批准号:
    10643568
  • 财政年份:
    2023
  • 资助金额:
    $ 39.46万
  • 项目类别:
MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS)
MUSIC 疗法解决镰状细胞病生活质量问题的多部位可行性 (MULTI-MUSIQOLS)
  • 批准号:
    10728452
  • 财政年份:
    2023
  • 资助金额:
    $ 39.46万
  • 项目类别:
Contact Pathway Inhibitor to Prevent Vascular Access Failure
接触途径抑制剂以防止血管通路失败
  • 批准号:
    10604057
  • 财政年份:
    2023
  • 资助金额:
    $ 39.46万
  • 项目类别:
Stroke Prevention in Nigeria: SPRING 2
尼日利亚的中风预防:春季 2
  • 批准号:
    10741173
  • 财政年份:
    2023
  • 资助金额:
    $ 39.46万
  • 项目类别:
Use of radioprotector in rectal cancer
放射防护剂在直肠癌中的应用
  • 批准号:
    10367001
  • 财政年份:
    2022
  • 资助金额:
    $ 39.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了